# Monopar Therapeutics Inc. (MNPR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MNPR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -14.04M | $ -12.49M | $ 154.92M | $ 137.83B |
| 2024 | $ 0 | $ -16.38M | $ -6.73M | $ 0 | $ 55.04M |
| 2023 | $ 0 | $ -9.08M | $ -8.50M | $ 0 | $ 5.59M |
| 2022 | $ 0 | $ -11.75M | $ -8.03M | $ 8.4K | $ 10.09M |
| 2021 | $ 0 | $ -10.82M | $ -8.70M | $ 0 | $ 18.94M |
| 2020 | $ 0 | $ -8.03M | $ -5.94M | $ 0 | $ 15.69M |
| 2019 | $ 0 | $ -5.45M | $ -3.90M | $ 0 | $ 12.63M |
| 2018 | $ 0 | $ -4.26M | $ -3.81M | $ 0 | $ 6.92M |
| 2017 | $ 0 | $ -22.30M | $ -3.54M | $ 0 | $ 9.62M |
| 2016 | $ 0 | $ -1.63M | $ -1.6K | $ 0 | $ 2.83M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.02 |
| Current Ratio | 51.35 |

## Other views

- [Metrics](https://sponda.capital/en/MNPR.md)
- [Charts](https://sponda.capital/en/MNPR/charts.md)
- [Compare](https://sponda.capital/en/MNPR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.